M&A in Consumer Health in an Era of Uncertainty: Evaluating 2022 and Beyond

M&A in Consumer Health in an Era of Uncertainty: Evaluating 2022 and Beyond

In 2021, mergers and acquisitions in consumer health roared back, as economies opened up and consumer sentiment rode high from widespread vaccine access and unprecedented fiscal stimulus, to see its highest gains in years. However, the boom in M&A in 2021 had already dried up in the first half of 2022, under the weight of inflationary pressures and supply chain bottlenecks. This softening is expected to continue at least until the end of 2022, and might constrain transactions in the forecast per...

Euromonitor International’s M&A in Consumer Health in an Era of Uncertainty: Evaluating 2022 and Beyond global briefing examines the size, growth trends and potential opportunities in the Consumer Health market.  The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies.  Consumer attitudes towards the products and their personal healthcare needs are also explored.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.